{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T05:21:17Z","timestamp":1741238477257,"version":"3.38.0"},"reference-count":46,"publisher":"JLE","issue":"3","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.nephro.2009.10.003","type":"journal-article","created":{"date-parts":[[2010,3,26]],"date-time":"2010-03-26T14:40:06Z","timestamp":1269614406000},"page":"162-170","source":"Crossref","is-referenced-by-count":3,"title":["La pharmacop\u00e9e de pr\u00e9vention cardiovasculaire est-elle sous-utilis\u00e9e chez les patients souffrant d\u2019insuffisance r\u00e9nale chronique apr\u00e8s un infarctus du myocarde\u00a0?"],"prefix":"10.1684","volume":"6","author":[{"given":"H\u00e9lo\u00efse","family":"Cardinal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Madore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18929","reference":[{"key":"10.1016\/j.nephro.2009.10.003_bib1","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1053\/ajkd.2001.27392","article-title":"Cardiovascular disease in end-stage renal disease patients","volume":"38","author":"Collins","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2009.10.003_bib2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1523-1755.2000.00173.x","article-title":"Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients","volume":"58","author":"Cheung","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2009.10.003_bib3","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1053\/j.ajkd.2004.10.013","article-title":"Association of heart disease with diabetes and hypertension in patients with ESRD","volume":"45","author":"Xue","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2009.10.003_bib4","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1523-1755.2004.00465.x","article-title":"Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease","volume":"65","author":"Oberg","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2009.10.003_bib5","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/01.ASN.0000111744.00916.E6","article-title":"The role of oxidative stress-altered lipoprotein structure and function and microinflammation on cardiovascular risk in patients with minor renal dysfunction","volume":"15","author":"Kaysen","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2009.10.003_bib6","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1056\/NEJMoa041365","article-title":"Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction","volume":"351","author":"Anavekar","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2009.10.003_bib7","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0828-282X(06)70310-5","article-title":"Canadian Cardiovascular Society position statement--recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease","volume":"22","author":"McPherson","year":"2006","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.nephro.2009.10.003_bib8","unstructured":"Kidney Disease Outcomes Quality Initiative (K\/DOQI) Group. K\/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease. Am J Kidney Dis 2003;41:S1\u201391."},{"key":"10.1016\/j.nephro.2009.10.003_bib9","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0140-6736(08)61237-4","article-title":"Acute myocardial infarction","volume":"372","author":"White","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2009.10.003_bib10","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJM199805213382106","article-title":"The treatment of unrelated disorders in patients with chronic medical diseases","volume":"338","author":"Redelmeier","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2009.10.003_bib11","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.amjmed.2005.08.057","article-title":"Chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes","volume":"119","author":"Han","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.nephro.2009.10.003_bib12","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1097\/01.ASN.0000135969.33773.0B","article-title":"\u201cRenalism\u201d: inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency","volume":"15","author":"Chertow","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2009.10.003_bib13","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1001\/archinte.166.18.2027","article-title":"Recent trends in the care of patients with non-ST segment elevation acute coronary syndromes: insights from the CRUSADE initiative","volume":"166","author":"Mehta","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.nephro.2009.10.003_bib14","unstructured":"Wells GA, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.htm."},{"key":"10.1016\/j.nephro.2009.10.003_bib15","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.amjcard.2004.08.035","article-title":"Prognostic significance of renal insufficiency in patients presenting with acute coronary syndrome (the Prospective Multicenter SYCOMORE study)","volume":"94","author":"Dumaine","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.nephro.2009.10.003_bib16","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.amjcard.2008.04.040","article-title":"Impact of optimal medical therapy and revascularization on outcome of patients with chronic kidney disease and on dialysis who presented with acute coronary syndrome","volume":"102","author":"Bonello","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.nephro.2009.10.003_bib17","first-page":"35","article-title":"Renal failure in patients after acute coronary syndrome--does it change the standards? From theory to practice","volume":"62","author":"Filipiak","year":"2005","journal-title":"Przegl Lek"},{"key":"10.1016\/j.nephro.2009.10.003_bib18","first-page":"222","article-title":"Low utilization of secondary preventive medications and its potential impact in patients with chronic kidney disease and acute coronary syndromes","volume":"58","author":"Harada","year":"2006","journal-title":"Indian Heart J"},{"key":"10.1016\/j.nephro.2009.10.003_bib19","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2215\/CJN.02010408","article-title":"Associations of kidney function with cardiovascular medication use after myocardial infarction","volume":"3","author":"Winkelmayer","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2009.10.003_bib20","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1111\/j.1532-5415.2005.53520.x","article-title":"Predictors of overall quality of care provided to vulnerable older people","volume":"53","author":"Min","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.nephro.2009.10.003_bib21","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1001\/jama.294.10.1240","article-title":"Risk-treatment mismatch in the pharmacotherapy of heart failure","volume":"294","author":"Lee","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.nephro.2009.10.003_bib22","doi-asserted-by":"crossref","first-page":"563","DOI":"10.7326\/0003-4819-137-7-200210010-00007","article-title":"Acute myocardial infarction and renal dysfunction: a high risk combination","volume":"137","author":"Wright","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.nephro.2009.10.003_bib23","doi-asserted-by":"crossref","first-page":"555","DOI":"10.7326\/0003-4819-137-7-200210010-00006","article-title":"Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients","volume":"137","author":"Shlipak","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.nephro.2009.10.003_bib24","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1053\/ajkd.2001.24522","article-title":"Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction","volume":"37","author":"Beattie","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2009.10.003_bib25","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1053\/j.ajkd.2005.07.043","article-title":"Outcomes of acute coronary syndrome in a large Canadian cohort: impact of chronic renal insufficiency, cardiac interventions, and anemia","volume":"46","author":"Keough-Ryan","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2009.10.003_bib26","doi-asserted-by":"crossref","unstructured":"Cardinal H, Bogaty P, Madore F, Boyer L, Joseph L, Brophy JM. Therapeutic management in patients with renal failure who experience an acute coronary syndrome. Clin J Am Soc Nephrol 2010;5:87\u201394.","DOI":"10.2215\/CJN.04290609"},{"key":"10.1016\/j.nephro.2009.10.003_bib27","doi-asserted-by":"crossref","unstructured":"Antithrombotic Trialist's Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71\u201386.","DOI":"10.1136\/bmj.324.7329.71"},{"key":"10.1016\/j.nephro.2009.10.003_bib28","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1136\/bmj.318.7200.1730","article-title":"beta Blockade after myocardial infarction: systematic review and meta regression analysis","volume":"318","author":"Freemantle","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.nephro.2009.10.003_bib29","unstructured":"GISSI-3. Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6\u00a0week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell\u2019infarto Miocardico. Lancet 1994;343:1115\u201322."},{"key":"10.1016\/j.nephro.2009.10.003_bib30","doi-asserted-by":"crossref","unstructured":"ISIS-4. A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050\u00a0patients with suspected acute myocardial infarction. ISIS-4 (Fourth international study of infarct survival) Collaborative Group. Lancet 1995;345:669\u201385.","DOI":"10.1016\/S0140-6736(95)90865-X"},{"key":"10.1016\/j.nephro.2009.10.003_bib31","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJMoa032292","article-title":"Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both","volume":"349","author":"Pfeffer","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2009.10.003_bib32","doi-asserted-by":"crossref","unstructured":"Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444\u00a0patients with coronary heart disease. The Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383\u20139.","DOI":"10.1016\/S0140-6736(94)90566-5"},{"key":"10.1016\/j.nephro.2009.10.003_bib33","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1038\/sj.ki.5001934","article-title":"The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease","volume":"70","author":"Charytan","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2009.10.003_bib34","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/01.ASN.0000100125.21491.46","article-title":"The number, quality, and coverage of randomized controlled trials in nephrology","volume":"15","author":"Strippoli","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2009.10.003_bib35","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1023\/B:THRO.0000024050.78728.35","article-title":"Aspirin use post-acute coronary syndromes: intolerance, bleeding and discontinuation","volume":"16","author":"Newby","year":"2003","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.nephro.2009.10.003_bib36","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1053\/j.ajkd.2004.11.015","article-title":"First United Kingdom heart and renal protection (UK-HARP-I) study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease","volume":"45","author":"Baigent","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2009.10.003_bib37","doi-asserted-by":"crossref","first-page":"629","DOI":"10.7326\/0003-4819-134-8-200104170-00007","article-title":"Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial","volume":"134","author":"Mann","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.nephro.2009.10.003_bib38","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1161\/01.CIR.0000149806.01354.BF","article-title":"Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the survival and ventricular enlargement (SAVE) study","volume":"110","author":"Tokmakova","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.nephro.2009.10.003_bib39","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/sj.ki.5001657","article-title":"Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies","volume":"70","author":"Zannad","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2009.10.003_bib40","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.jacc.2007.11.072","article-title":"Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study","volume":"51","author":"Shepherd","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nephro.2009.10.003_bib41","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1161\/01.CIR.0000143892.84582.60","article-title":"Effect of pravastatin on cardiovascular events in people with chronic kidney disease","volume":"110","author":"Tonelli","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.nephro.2009.10.003_bib42","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1136\/bmj.39472.580984.AE","article-title":"Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials","volume":"336","author":"Strippoli","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.nephro.2009.10.003_bib43","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa0810177","article-title":"Rosuvastatin and cardiovascular events in patients undergoing hemodialysis","volume":"360","author":"Fellstrom","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2009.10.003_bib44","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2\u00a0diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2009.10.003_bib45","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1161\/CIRCULATIONAHA.107.696765","article-title":"Clinical characteristics of dialysis patients with acute myocardial infarction in the United States","volume":"116","author":"Herzog","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.nephro.2009.10.003_bib46","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1093\/ndt\/gfh981","article-title":"Renal function, concomitant medication use and outcomes following acute coronary syndromes","volume":"20","author":"Reddan","year":"2005","journal-title":"Nephrol Dial Transplant"}],"container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725509002910?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725509002910?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2009.10.003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T14:43:47Z","timestamp":1741185827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769725509002910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S1769725509002910"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2009.10.003","relation":{},"ISSN":["1769-7255"],"issn-type":[{"type":"print","value":"1769-7255"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}